Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by RFG Advisory LLC

RFG Advisory LLC trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,699 shares of the biotechnology company’s stock after selling 390 shares during the quarter. RFG Advisory LLC’s holdings in Axon Enterprise were worth $1,604,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC raised its holdings in Axon Enterprise by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after acquiring an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP lifted its position in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC boosted its stake in Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after buying an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth $200,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 0.5 %

AXON opened at $610.32 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market capitalization of $46.54 billion, a price-to-earnings ratio of 157.71, a PEG ratio of 6.09 and a beta of 1.04. The business has a fifty day moving average price of $617.65 and a 200 day moving average price of $470.75. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 20,000 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock valued at $30,721,337 over the last 90 days. 6.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AXON. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group increased their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.